Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 5 studies | 35% ± 18% | |
retinal rod cell | 3 studies | 24% ± 5% | |
GABAergic neuron | 3 studies | 37% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 26% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 88% | 4268.42 | 2335 / 2642 | 92% | 16.03 | 647 / 705 |
prostate | 77% | 758.18 | 189 / 245 | 72% | 3.36 | 363 / 502 |
thymus | 20% | 113.55 | 129 / 653 | 90% | 13.02 | 544 / 605 |
muscle | 100% | 6487.04 | 802 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 14% | 97.63 | 36 / 258 | 85% | 20.99 | 195 / 230 |
kidney | 57% | 483.96 | 51 / 89 | 37% | 5.16 | 335 / 901 |
heart | 92% | 1668.42 | 788 / 861 | 0% | 0 | 0 / 0 |
ovary | 51% | 437.62 | 91 / 180 | 18% | 0.75 | 77 / 430 |
stomach | 57% | 363.60 | 206 / 359 | 9% | 0.48 | 25 / 286 |
intestine | 56% | 626.71 | 542 / 966 | 7% | 0.37 | 39 / 527 |
breast | 14% | 96.98 | 66 / 459 | 47% | 3.38 | 524 / 1118 |
blood vessel | 47% | 466.10 | 629 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 3.34 | 21 / 45 |
pancreas | 0% | 1.76 | 1 / 328 | 43% | 3.42 | 77 / 178 |
liver | 3% | 13.70 | 6 / 226 | 30% | 1.57 | 120 / 406 |
uterus | 13% | 88.19 | 22 / 170 | 17% | 2.06 | 79 / 459 |
lung | 0% | 1.64 | 1 / 578 | 16% | 1.33 | 183 / 1155 |
skin | 10% | 63.04 | 175 / 1809 | 6% | 0.34 | 27 / 472 |
adipose | 15% | 90.54 | 178 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 1% | 4.53 | 13 / 1445 | 13% | 0.93 | 24 / 183 |
peripheral blood | 7% | 62.70 | 69 / 929 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 7% | 0.39 | 36 / 504 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.40 | 2 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.45 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | UBE2QL1 |
Protein name | Ubiquitin-conjugating enzyme E2Q-like protein 1 (EC 2.3.2.23) (E2Q-like ubiquitin-conjugating enzyme 1) |
Synonyms | |
Description | FUNCTION: Probable E2 ubiquitin-protein ligase that catalyzes the covalent attachment of ubiquitin to target proteins. May facilitate the monoubiquitination and degradation of MTOR and CCNE1 through interaction with FBXW7. . |
Accessions | ENST00000399816.4 ENST00000708565.1 A1L167 |